May, 2007:
Data reveals siblings of diabetics have an extremely high risk of developing vaccine induced diabetes. The hemophilus vaccine for example may cause over 2% of these children to develop diabetes. Other vaccines have an effect of similar magnitude. US Senators have writen FDA to take action however no action has yet been taken.For more information GO HERE
John Barthelow Classen, M. D., M. B. A., is President and Chief Executive Officer of Classen Immunotherapies. Besides overseeing development of the company's products, he has acted as a biotechnology consultant advising several New York investment firms. Dr. Classen was employed at the National Institutes of Health in the Laboratory of Immunology, NIAID, between 1988 and 1991 before leaving to found Classen Immunotherapies in 1991. He received his M.D. from the University of Maryland in 1988 and his M.B.A. from Columbia University in 1992
Friday, July 06, 2007
Subscribe to:
Post Comments (Atom)

0 comments:
Post a Comment